BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 11141495)

  • 1. Interferon-gamma acts directly on rejecting renal allografts to prevent graft necrosis.
    Halloran PF; Afrouzian M; Ramassar V; Urmson J; Zhu LF; Helms LM; Solez K; Kneteman NM
    Am J Pathol; 2001 Jan; 158(1):215-26. PubMed ID: 11141495
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transcription factor IRF-1 in kidney transplants mediates resistance to graft necrosis during rejection.
    Afrouzian M; Ramassar V; Urmson J; Zhu LF; Halloran PF
    J Am Soc Nephrol; 2002 May; 13(5):1199-209. PubMed ID: 11961007
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IFN-gamma alters the pathology of graft rejection: protection from early necrosis.
    Halloran PF; Miller LW; Urmson J; Ramassar V; Zhu LF; Kneteman NM; Solez K; Afrouzian M
    J Immunol; 2001 Jun; 166(12):7072-81. PubMed ID: 11390451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Central role for interferon-gamma receptor in the regulation of renal MHC expression.
    Takei Y; Sims TN; Urmson J; Halloran PF
    J Am Soc Nephrol; 2000 Feb; 11(2):250-261. PubMed ID: 10665932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Donor IFN-gamma receptors are critical for acute CD4(+) T cell-mediated cardiac allograft rejection.
    Wiseman AC; Pietra BA; Kelly BP; Rayat GR; Rizeq M; Gill RG
    J Immunol; 2001 Nov; 167(9):5457-63. PubMed ID: 11673565
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neutrophils mediate parenchymal tissue necrosis and accelerate the rejection of complete major histocompatibility complex-disparate cardiac allografts in the absence of interferon-gamma.
    Miura M; El-Sawy T; Fairchild RL
    Am J Pathol; 2003 Feb; 162(2):509-19. PubMed ID: 12547709
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MHC-matched corneal allograft rejection in an IFN-gamma/IL-17-independent manner in C57BL/6 mice.
    Yamada J; Hamuro J; Fukushima A; Ohteki T; Terai K; Iwakura Y; Yagita H; Kinoshita S
    Invest Ophthalmol Vis Sci; 2009 May; 50(5):2139-46. PubMed ID: 19136699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD4+ T-cell-dependent immune damage of liver parenchymal cells is mediated by alloantibody.
    Horne PH; Lunsford KE; Eiring AM; Wang Y; Gao D; Bumgardner GL
    Transplantation; 2005 Aug; 80(4):514-21. PubMed ID: 16123727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impaired rejection and mucosal injury of small intestinal allografts lacking the interferon-gamma receptor.
    Veitch AM; Higgins LM; Bajaj-Elliot M; Farthing MJ; MacDonald TT
    Int J Exp Pathol; 2003 Jun; 84(3):107-13. PubMed ID: 12974940
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mice deficient in interferon-gamma or interferon-gamma receptor 1 have distinct inflammatory responses to acute viral encephalomyelitis.
    Lee EY; Schultz KL; Griffin DE
    PLoS One; 2013; 8(10):e76412. PubMed ID: 24204622
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coronary arteriosclerosis after T-cell-mediated injury in transplanted mouse hearts: role of interferon-gamma.
    Nagano H; Libby P; Taylor MK; Hasegawa S; Stinn JL; Becker G; Tilney NL; Mitchell RN
    Am J Pathol; 1998 May; 152(5):1187-97. PubMed ID: 9588888
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Changes in the transcriptome in allograft rejection: IFN-gamma-induced transcripts in mouse kidney allografts.
    Famulski KS; Einecke G; Reeve J; Ramassar V; Allanach K; Mueller T; Hidalgo LG; Zhu LF; Halloran PF
    Am J Transplant; 2006 Jun; 6(6):1342-54. PubMed ID: 16686758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Up-regulated intragraft gene expression, ICAM-1 and IL-2R molecules, and apoptotic epithelial cells during rejection of rat small intestine allografts.
    Li Y; Li N; Li Y; Wu B; Li J
    Chin Med J (Engl); 2001 Oct; 114(10):1089-94. PubMed ID: 11677773
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Heart transplants in interferon-gamma, interleukin 4, and interleukin 10 knockout mice. Recipient environment alters graft rejection.
    Räisänen-Sokolowski A; Mottram PL; Glysing-Jensen T; Satoskar A; Russell ME
    J Clin Invest; 1997 Nov; 100(10):2449-56. PubMed ID: 9366559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interferon-gamma and donor MHC class I control alternative macrophage activation and activin expression in rejecting kidney allografts: a shift in the Th1-Th2 paradigm.
    Famulski KS; Sis B; Billesberger L; Halloran PF
    Am J Transplant; 2008 Mar; 8(3):547-56. PubMed ID: 18294151
    [TBL] [Abstract][Full Text] [Related]  

  • 16. IFN-gamma is an absolute requirement for spontaneous acceptance of liver allografts.
    Mele TS; Kneteman NM; Zhu LF; Ramassar V; Urmson J; Halloran B; Churchill TA; Jewell L; Kane K; Halloran PF
    Am J Transplant; 2003 Aug; 3(8):942-51. PubMed ID: 12859528
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Kinetics of intragraft cytokine expression, cellular infiltration, and cell death in rejection of renal allografts compared with acceptance of liver allografts in a rat model: early activation and apoptosis is associated with liver graft acceptance.
    Sharland A; Shastry S; Wang C; Rokahr K; Sun J; Sheil AG; McCaughan GW; Bishop GA
    Transplantation; 1998 May; 65(10):1370-7. PubMed ID: 9625021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. IFN-gamma prevents early perforin-granzyme-mediated destruction of kidney allografts by inducing donor class I products in the kidney.
    Sis B; Famulski KS; Allanach KL; Zhu LF; Halloran PF
    Am J Transplant; 2007 Oct; 7(10):2301-10. PubMed ID: 17845563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Th2-predominant inflammation and blockade of IFN-gamma signaling induce aneurysms in allografted aortas.
    Shimizu K; Shichiri M; Libby P; Lee RT; Mitchell RN
    J Clin Invest; 2004 Jul; 114(2):300-8. PubMed ID: 15254597
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased expression of IL-4 and IL-10 and decreased expression of IL-2 and interferon-gamma in long-surviving mouse heart allografts after brief CD4-monoclonal antibody therapy.
    Mottram PL; Han WR; Purcell LJ; McKenzie IF; Hancock WW
    Transplantation; 1995 Feb; 59(4):559-65. PubMed ID: 7878761
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.